REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Equitecmed CIA Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Equitecmed CIA Ltda Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Equitecmed CIA Ltda is based in Ecuador, with the head office in Quito. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on September 28, 2005. 2 (2023) employees currently work for Equitecmed CIA Ltda. From the latest financial highlights, Equitecmed CIA Ltda reported a net sales revenue drop of 41.47% in 2023. Its total assets decreased by 6.98% over the same period.

Headquarters
Mallorca N24-313
Quito; Pichincha;

Contact Details: Purchase the Equitecmed CIA Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Equitecmed CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Equitecmed CIA Ltda report to view the information.
Registered Capital:
Purchase the Equitecmed CIA Ltda report to view the information.
Incorporation Date:
September 28, 2005
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
80.47%
Purchase this report to view the information.
9.77%
Purchase this report to view the information.
9.77%
Company Performance
Financial values in the chart are available after Equitecmed CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-41.47%▼
Total operating revenue
10.54%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-6.98%▼
Total equity
-25.02%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
14.97%▲
Quick Ratio
-0.4%▼
Cash Ratio
-0.64%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo